Samlyn Capital, LLC Bristol Myers Squibb CO Transaction History

Samlyn Capital, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $70.1 Million - $81.7 Million	-1,306,491 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $33.6 Million - $39.4 Million	-568,213 Reduced 30.31%	1,306,491 $77.3 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $19.1 Million - $20.8 Million	307,938 Added 19.65%	1,874,704 $125 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $3.54 Million - $3.98 Million	59,678 Added 3.96%	1,566,766 $98.9 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $44.5 Million - $50.4 Million	770,667 Added 104.65%	1,507,088 $93.5 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $13.5 Million - $14.9 Million	234,653 Added 46.77%	736,421 $44.4 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $27.5 Million - $32.2 Million	501,768 New	501,768 $29.5 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $35.4 Million - $51.5 Million	-763,174 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $7.09 Million - $9.25 Million	-144,034 Reduced 15.88%	763,174 $49 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $12.7 Million - $15 Million	-296,071 Reduced 24.61%	907,208 $46 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $37.3 Million - $41.2 Million	836,027 Added 227.64%	1,203,279 $54.6 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $5.74 Million - $6.84 Million	-127,107 Reduced 25.71%	367,252 $17.5 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $24.1 Million - $31.3 Million	494,359 New	494,359 $25.7 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.